ES2486116B1 - ANTIBODY AGAINST DANIO RERIO TYPE DELTA1b OPIOID RECEIVER - Google Patents

ANTIBODY AGAINST DANIO RERIO TYPE DELTA1b OPIOID RECEIVER Download PDF

Info

Publication number
ES2486116B1
ES2486116B1 ES201330192A ES201330192A ES2486116B1 ES 2486116 B1 ES2486116 B1 ES 2486116B1 ES 201330192 A ES201330192 A ES 201330192A ES 201330192 A ES201330192 A ES 201330192A ES 2486116 B1 ES2486116 B1 ES 2486116B1
Authority
ES
Spain
Prior art keywords
delta1b
opioid receptor
type
danio rerio
antibody against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES201330192A
Other languages
Spanish (es)
Other versions
ES2486116A1 (en
Inventor
Juan Carlos ARÉVALO MARTÍN
Raquel E. RODRÍGUEZ RODRÍGUEZ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidad de Salamanca
Original Assignee
Universidad de Salamanca
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad de Salamanca filed Critical Universidad de Salamanca
Priority to ES201330192A priority Critical patent/ES2486116B1/en
Publication of ES2486116A1 publication Critical patent/ES2486116A1/en
Application granted granted Critical
Publication of ES2486116B1 publication Critical patent/ES2486116B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Anticuerpo frente al receptor opioide tipo Delta1b de danio rerio.#La presente invención proporciona anticuerpos, preferiblemente policlonales, específicos frente al receptor opioide tipo Delta1b de pez cebra, los cuales son capaces de reconocer dicho receptor específicamente sin presentar reactividad cruzada con otros tipos receptores opioides. Además, la invención proporciona un antígeno del receptor opioide tipo Delta1b de pez cebra empleado para la generación de dichos anticuerpos, así como un método de obtención de dichos anticuerpos y un kit que comprende dichos anticuerpos para la detección del receptor opioide tipo Delta1b de pez cebra.Antibody to the danio rerio Delta1b opioid receptor. # The present invention provides antibodies, preferably polyclonal, specific to the zebrafish Delta1b opioid receptor, which are capable of recognizing said receptor specifically without presenting cross-reactivity with other opioid receptor types. . In addition, the invention provides a zebrafish Delta1b opioid receptor antigen used for the generation of said antibodies, as well as a method of obtaining said antibodies and a kit comprising said antibodies for the detection of the zebrafish Delta1b opioid receptor .

Description

imagen1image 1

imagen2image2

imagen3image3

imagen4image4

imagen5image5

imagen6image6

imagen7image7

imagen8image8

imagen9image9

imagen10image10

imagen11image11

imagen12image12

imagen13image13

imagen14image14

imagen15image15

imagen16image16

imagen17image17

imagen18image18

imagen19image19

imagen20image20

imagen21image21

Claims (1)

imagen1image 1 imagen2image2
ES201330192A 2013-02-14 2013-02-14 ANTIBODY AGAINST DANIO RERIO TYPE DELTA1b OPIOID RECEIVER Active ES2486116B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES201330192A ES2486116B1 (en) 2013-02-14 2013-02-14 ANTIBODY AGAINST DANIO RERIO TYPE DELTA1b OPIOID RECEIVER

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201330192A ES2486116B1 (en) 2013-02-14 2013-02-14 ANTIBODY AGAINST DANIO RERIO TYPE DELTA1b OPIOID RECEIVER

Publications (2)

Publication Number Publication Date
ES2486116A1 ES2486116A1 (en) 2014-08-14
ES2486116B1 true ES2486116B1 (en) 2015-05-20

Family

ID=51300313

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201330192A Active ES2486116B1 (en) 2013-02-14 2013-02-14 ANTIBODY AGAINST DANIO RERIO TYPE DELTA1b OPIOID RECEIVER

Country Status (1)

Country Link
ES (1) ES2486116B1 (en)

Also Published As

Publication number Publication date
ES2486116A1 (en) 2014-08-14

Similar Documents

Publication Publication Date Title
CL2019003657A1 (en) Antibodies that specifically bind to cd38 useful for enhancing an immune response in a patient. (divisional request 201703275)
ECSP18038868A (en) ANTIBODY CONJUGATES INCLUDING A TOLL-TYPE RECEPTOR AGONIST
AR081750A1 (en) ANTI-CD40 ANTIBODIES
CR20180031A (en) ANTIBODIES MATURED BY AFFINITY AND HUMANIZED FOR FCRH5 AND METHODS FOR USE
BR112015021521A2 (en) anti-crth2 antibodies and methods for their use
MX337535B (en) Antibody, kit and method for determining amyloid peptides.
CR20160338A (en) ANTIBODIES AND METHODS OF USE
EA201790664A1 (en) ANTIBODIES AGAINST MEZOTELINE AND IMMUNOCONJUGATES
BR112016000106A2 (en) anti-complement factor c1q antibodies and uses thereof
CL2014001073A1 (en) Humanized antibodies that recognize alpha-synuclein; method to detect lewy bodies; method to inhibit synuclein aggregation or reduce lewy bodies.
CL2015002724A1 (en) Methods to treat crohn's disease using an anti-il23 antibody
AR094403A1 (en) ANTI-HER3 ANTIBODY COMBINATION THERAPY
TR201902171T4 (en) Method for capturing a molecule in a sample.
AR090668A1 (en) ANTI-ADAMTS-5 ANTIBODY, DERIVATIVES AND USES OF THE SAME
FR3001275B1 (en) DEVICE FOR DETECTING THE STATE OF A MOUNTING OF A COIL ON A SOLENOID VALVE.
BR112018007842A2 (en) immunoassay for detection of high molecular weight cleaved kininogen, method, isolated antibody, kit for detecting a high molecular weight cleaved kininogen (hmwk)
ES2486116B1 (en) ANTIBODY AGAINST DANIO RERIO TYPE DELTA1b OPIOID RECEIVER
EA201691091A1 (en) DIAGNOSTIC REAGENTS FOR IMPROVED IN VIVO OR IN VITRO CELL-MEDIATED IMMUNOLOGICAL DIAGNOSTICS OF TUBERCULOSIS
ES2486140B1 (en) ANTIBODY AGAINST THE OPIOID RECEIVER TYPE MU OF DANIO RERIO
MX2019008779A (en) Pseudomonas antigens and antigen combinations.
FR2997499B1 (en) DEVICE FOR TESTING THE INGESTION OF OBJECTS BY A TURBOMACHINE
AR104413A1 (en) IGF-1R ANTIBODY AND ITS USE TO DIAGNOSTIC CANCER
ES2544358B1 (en) Monoclonal antibody for the detection of total and specific IgM antigens in zebrafish
ES2538597B1 (en) Device for the detection of Shigella dysenteriae serotype 1
CL2017001813A1 (en) Method to diagnose chronic valvular disease.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2486116

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20150520